Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19.

Marchetti, Giulia; Rovito, Roberta; Bono, Valeria; Bonara, Paola; Bai, Francesca; Monforte, Antonella d'Arminio

Marchetti, Giulia; Rovito, Roberta; Bono, Valeria; Bonara, Paola; Bai, Francesca; Monforte, Antonella d'Arminio.

Marchetti G; Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy. Electronic address: giulia.marchetti@unimi.it.
Rovito R; Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy.
Bono V; Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy.
Bonara P; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Bai F; Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy.
Monforte AD; Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, Milan, Italy.

Clin Microbiol Infect ; 29(5): 660-662, 2023 05.

Article in English | MEDLINE | ID: covidwho-2177756

Subject(s)

COVID-19; Humans; Ritonavir/therapeutic use; COVID-19 Drug Treatment; Antiviral Agents/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google